India’s counterfeit drug crisis and the role of AI
India is facing a perilous rise in counterfeit high-value medicines, from cancer immunotherapies like Keytruda (pembrolizumab) to…
Author
How biomimicry is transforming personal care categories in India
India’s personal care industry is undergoing a fundamental shift in how it thinks about innovation. For years, the sector relied…
Dr. Reddy’s Laboratories launches its generic Semaglutide Injection in Canada
Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch of its generic Semaglutide Injection in Canada.…
Lupin inaugurates Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center in Delhi
Global pharma major Lupin announced the launch of Atharv Ability, its world-class neuro-rehabilitation center in Naraina Vihar,…
Indulekha Bringha Hair Growth Serum completes second clinical trial
Indulekha has announced the successful completion of its second large clinical study on the Indulekha Bringha Hair Growth Serum,…
Indoco Remedies clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good…
Zydus to acquire Assertio in all-cash tender offer
Assertio is focused on specialty and oncology supportive-care therapies
Lupin gets US FDA nod for Famotidine Injection, USP
This product would be manufactured at Lupin’s Nagpur facility in India
Lilly launches Lormalzi for treatment of early symptomatic Alzheimer’s Disease in India
Eli Lilly and Company (India) announced the launch of Lormalzi (donanemab, 350 mg/20 mL IV vial) in India, following marketing…
AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure, chronic kidney…
AstraZeneca Pharma India has launched K+ Connect, a pan-India multidisciplinary initiative focused on advancing the management of…